[144] Phreesia, Inc. SEC Filing

Rhea-AI Filing Summary

Phreesia (PHR): A selling securityholder filed a Form 144 to sell 885 shares of common stock, with an approximate sale date of 10/17/2025 on the NYSE and an aggregate market value of 19789.66.

The 885 shares were acquired via restricted stock vesting on 10/14/2025 as compensation from the issuer. Shares outstanding were 59914473.

Recent Form 144 activity by Balaji Gandhi shows sales of 886 shares on 07/17/2025 for 23820.82, 9583 shares on 08/25/2025 for 287550.07, and 4183 shares on 09/16/2025 for 97398.65.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	885	19789.66	59914473	10/17/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/14/2025	Restricted Stock Vesting	Issuer			885	10/14/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Balaji Gandhi 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	07/17/2025	886	23820.82
Balaji Gandhi 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	08/25/2025	9583	287550.07
Balaji Gandhi 1521 Concord Pike Suite 301 PMB 221 Wilmington DE 19803	Common	09/16/2025	4183	97398.65

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does PHR's Form 144 filing disclose?

It discloses a planned sale of 885 common shares on the NYSE with an approximate sale date of 10/17/2025 and an aggregate market value of 19789.66.

How were the 885 PHR shares acquired?

They were acquired via restricted stock vesting on 10/14/2025 as compensation from the issuer.

How many PHR shares are outstanding?

The filing lists 59914473 shares outstanding.

Which exchange is named for the planned sale?

The shares are slated for sale on the NYSE.

Who appears in recent PHR Form 144 sales and what were the amounts?

Balaji Gandhi sold 886 shares on 07/17/2025 for 23820.82, 9583 on 08/25/2025 for 287550.07, and 4183 on 09/16/2025 for 97398.65.

What class of PHR securities is involved?

The filing pertains to common shares.